IHH Healthcare, a leading global healthcare provider listed in Malaysia and Singapore, is significantly scaling its investments in India, positioning the country as a pivotal global business services hub. This strategic move extends India's role beyond direct hospital expansion, making it central to supporting IHH's operations across its international markets.
Expanding Hospital Network and Capacity
India remains one of IHH Healthcare's most important investment destinations. Through its subsidiary Fortis Healthcare, the company aims to expand its hospital network to 10,000 beds by 2030, with visibility already established for approximately 8,000 beds through brownfield expansions. IHH is actively pursuing operational and management (O&M) agreements and evaluating selective acquisitions, alongside potential greenfield opportunities.
Ashok Pandit, Group Chief Corporate Officer at IHH Healthcare, emphasized the country's strong and stable growth prospects. The expansion strategy will primarily focus on strengthening existing hospital clusters in major metropolitan areas including Delhi-NCR, Punjab, Mumbai, Bengaluru, Hyderabad, Tamil Nadu, and Kolkata, while remaining open to strategic opportunities in other regions.
Boosting Health Technology and Innovation
Beyond traditional hospital expansion, IHH Healthcare is significantly increasing its focus on the health technology sector in India. The group has an innovation fund of approximately SGD 80 million, much of which has already been committed to healthcare startups globally, particularly in areas like cancer diagnostics, digital health, proton therapy, mental health, and sleep disorders. This approach is now being systematically extended to the Indian market.
The company's "Catalyst programme" aims to identify and integrate promising Indian startups into its ecosystem, allowing them to collaborate within IHH's hospital network. Furthermore, IHH is investing in advanced technology across its hospitals to enhance clinical outcomes, improve patient experience, and optimize operational efficiency. Quek Sin Kwok, Group Chief Business Technology Officer, highlighted that technology spending is focused on delivering measurable improvements in care delivery and productivity, rather than just the amount spent.
Driving Efficiency and Patient Affordability
A key priority for IHH Healthcare in India is to improve productivity and manage rising healthcare costs without compromising patient care. Executives underscored the importance of making healthcare more efficient to prevent cost burdens from being passed on to patients. This objective will guide the company's strategic decisions over the next five to ten years, ensuring that investments in technology and operational improvements contribute to a more affordable and accessible healthcare system.
"India remains a very important core market for IHH. Through the Fortis platform, you will continue to see us make significant investments in hospitals, diagnostics and, increasingly, health-tech," said Ashok Pandit.
IHH Healthcare's comprehensive strategy in India underscores its long-term commitment to the market, with significant capital allocation directed towards hospitals, diagnostics, and a growing emphasis on health technology innovation.